
浏览全部资源
扫码关注微信
河南省中医院,郑州 450002
尉瑞,硕士,副主任中医师,从事中医治疗耳鼻咽喉疾病的研究,E-mail:zhang999doctor@163.com
李静波,硕士,主任医师,从事中西医结合治疗耳鼻咽喉疾病的研究,Tel:0371-60906441,E-mail:lihui333zy@sina.com
收稿日期:2021-06-09,
网络出版日期:2022-03-23,
纸质出版日期:2022-11-20
移动端阅览
尉瑞,陈璐璐,李静波等.补肺黄芪汤加减联合针刺治疗中重度变应性鼻炎肺肾虚寒证的临床疗效[J].中国实验方剂学杂志,2022,28(22):131-136.
WEI Rui,CHEN Lulu,LI Jingbo,et al.Modified Bufei Huangqitang Combined with Acupuncture in Treatment of Moderate-to-severe Allergic Rhinitis due to Deficiency and Cold in Lung and Kidney[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(22):131-136.
尉瑞,陈璐璐,李静波等.补肺黄芪汤加减联合针刺治疗中重度变应性鼻炎肺肾虚寒证的临床疗效[J].中国实验方剂学杂志,2022,28(22):131-136. DOI: 10.13422/j.cnki.syfjx.20222192.
WEI Rui,CHEN Lulu,LI Jingbo,et al.Modified Bufei Huangqitang Combined with Acupuncture in Treatment of Moderate-to-severe Allergic Rhinitis due to Deficiency and Cold in Lung and Kidney[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(22):131-136. DOI: 10.13422/j.cnki.syfjx.20222192.
目的
2
观察补肺黄芪汤加减联合针刺治疗中重度变应性鼻炎肺肾虚寒证的临床疗效。
方法
2
130例患者按随机数字表法分为对照组和观察组,每组65例。对照组给予盐酸西替利嗪片(每晚10 mg)联合糠酸莫米松鼻喷雾剂(每侧鼻腔1揿,每日1次),观察组给予针刺(每日1次)联合补肺黄芪汤加减(每次1/2剂,每日2次),均连续治疗15 d。治疗前后分别观察两组鼻炎患者生命质量调查量表(RQLQ)、鼻炎患者主要症状量表(TNSS)、鼻呼道阻力指数(NAR)、中医辨证变应性鼻炎肺肾虚寒证(中医证状)评分。检测两组鼻腔分泌物中神经肽Y(NPY)、血管活性肠肽(VIP)、P物质(SP),血清免疫炎性指标[嗜酸性粒细胞(EOS)、嗜酸粒细胞趋化酞(EOT)、免疫球蛋白E(IgE)、白细胞介素-33(IL-33)]的水平。观察研究期间两组出现的不良反应。
结果
2
观察组总有效率96.9%(63/65),高于对照组的81.5%(53/65),差异具有统计学意义(
χ
2
=7.943,
P
<
0.05)。观察组治疗后RQLQ、TNSS、NAR、中医证状低于对照组(
P
<
0.05)。观察组鼻分泌液中NPY水平高于对照组(
P
<
0.05),VIP、SP水平低于对照组(
P
<
0.05)。观察组血清EOS、IgE、IL-33水平低于对照组(
P
<
0.05),EOT水平高于对照组(
P
<
0.05)。对照组出现不良反应2例,观察组出现不良反应1例,两组不良反应发生率差异无统计学意义。
结论
2
补肺黄芪汤加减联合针刺可明显缓解中重度变应性鼻炎肺肾虚寒证的临床症状,改善血清免疫炎性指标水平,且安全性良好。
Objective
2
To observe the clinical efficacy of modified Bufei Huangqitang combined with acupuncture on moderate-to-severe allergic rhinitis due to deficiency and cold in lung and kidney.
Method
2
A total of 130 patients were divided into a control group (65 cases) and an observation group (65 cases) according to a random number table. The patients in the control group were treated with cetirizine hydrochloride tablets (10 mg per night) combined with mometasone furoate nasal spray (one press on each side,once a day),and those in the observation group were treated with acupuncture (once a day) combined with modified Bufei Huangqitang(1/2 dose each time,twice a day) for 15 days. The rhinoconjunctivitis quality of life questionnaire (RQLQ),total nasal symptom score (TNSS),nasal airway resistance (NAR),and traditional Chinese medicine (TCM) syndrome score of allergic rhinitis with deficiency and cold in lung and kidney syndrome were observed before and after treatment in two groups. The neuropeptide Y (NPY),vasoactive intestinal peptide (VIP),substance P (SP) in nasal secretions, and immune inflammatory markers [eosinophil (EOS),eotaxin (EOT),immunoglobulin E (IgE),and interleukin-33 (IL-33)] in serum were detected. Adverse reactions of the two groups were observed during the study period.
Result
2
The total effective rate was 96.9% (63/65) in the observation group, higher than 81.5% (53/65) in the control group (
χ
2
=7.943,
P
<
0.05). After treatment,the RQLQ,TNSS,NAR, and TCM syndrome scores in the observation group were lower than those in the control group (
P
<
0.05). The nasal secretions NPY in the observation group was higher than that in the control group (
P
<
0.05),while VIP and SP in the observation group were lower than those in the control group (
P
<
0.05). The serum EOS,IgE, and IL-33 in the observation group were lower than those in the control group (
P
<
0.05), while the serum EOT in the observation group was higher than those in the control group (
P
<
0.05). Adverse reactions occurred in two cases in the control group and one case in the observation group. The incidence of adverse reactions had no statistical significance between the two groups.
Conclusion
2
Acupuncture combined with modified Bufei huangqitang can significantly relieve the clinical symptoms of moderate-to-severe allergic rhinitis due to deficiency and cold in lung and kidney and improve the serum immune inflammatory markers, with good safety.
洪冬冬 , 彭顺林 , 苏俊桦 , 等 . 摄涕止鼽汤联合揿针治疗肺气虚寒型变应性鼻炎的临床观察 [J]. 中国实验方剂学杂志 , 2021 , 27 ( 2 ): 80 - 86 .
ZHANG Y , ZHANG L . Prevalence of allergic rhinitis in China [J]. Allergy Asthma Immunol Res , 2014 , 6 ( 2 ): 105 - 113 .
王孟 , 郑铭 , 王向东 , 等 . 中国过敏性鼻炎流行病学研究进展 [J]. 中国耳鼻咽喉头颈外科 , 2019 , 26 ( 8 ): 415 - 420 .
罗玉 , 古庆家 . 变应性鼻炎的治疗进展 [J]. 实用医院临床杂志 , 2021 , 18 ( 3 ): 211 - 213 .
CHOI S M , PARK J E , LI S S , et al . A multicenter,randomized,controlled trial testing the effects of acupuncture on allergic rhinitis [J]. Allergy , 2013 , 68 ( 3 ): 365 - 374 .
张晓阳 , 连增林 , 孙劲旅 , 等 . 祛风胜湿法治疗变应性鼻炎的理论与临床依据 [J]. 中国实验方剂学杂志 , 2020 , 26 ( 20 ): 198 - 205 .
张罗 , BACHERT C , FOKKENS W J , 等 . 《过敏性鼻炎及其对哮喘的影响(ARIA)》指南2019版过敏性鼻炎管理路径(中国版) [J]. 中国耳鼻咽喉头颈外科 , 2019 , 26 ( 12 ): 690 - 699 .
庞伟 . 变应性鼻炎的治疗方法进展 [J]. 继续医学教育 , 2021 , 35 ( 1 ): 77 - 79 .
SEIDMAN M D , GUREGEL R K , LIN S Y , et al . Clinical practice guideline:Allergic rhinitis [J]. Otolaryngol Head Neck Surg , 2015 , 152 ( 1 Suppl ): S1 - S43 .
王媛媛 , 孙瑞华 . PASS软件实现临床试验中非劣效、等效和优效性检验的样本量估算 [J]. 中华流行病学杂志 , 2016 , 37 ( 5 ): 741 - 744 .
中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组 , 中华医学会耳鼻咽喉头颈外科学分会鼻科学组 . 变应性鼻炎诊断和治疗指南(2015年,天津) [J]. 中华耳鼻咽喉头颈外科杂志 , 2016 , 51 ( 1 ): 6 - 24 .
陈潮祖 . 中医治法与方剂 [M]. 5版 . 北京 : 人民卫生出版社 , 2018 : 777 - 779 .
DIETZDELOOS D A , SEGBOER C L , GEVORGYAN A , et al . Disease-specific quality-of-life questionnaires in rhinitis and rhinosinusitis:review and evaluation [J]. Curr Allergy Asthma Rep , 2013 , 13 ( 2 ): 162 - 170 .
PRENNER B M , CHERVINSKY P , HAMPEL F C , et al . Double-strength beclomethasone dipropionate (84 micrograms/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis [J]. J Allergy Clin Immunol , 1996 , 98 ( 2 ): 302 - 308 .
王雅琦 , 骆斌 , 赵蔚波 , 等 . 177例变应性鼻炎患者的中医体质类型分布以及与焦虑抑郁状态的相关性探析 [J]. 北京中医药大学学报 , 2021 , 44 ( 6 ): 544 - 549 .
BROŻEK J L , BOUSQUET J , AGACHE I , et al . Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision [J]. J Allergy Clin Immunol , 2017 , 140 ( 4 ): 950 - 958 .
徐浩 , 董红军 , 陈旭青 , 等 . 《中医治未病实践指南·鼻鼽》临床一致性评价研究 [J]. 中国中医药信息杂志 , 2018 , 25 ( 3 ): 16 - 18 .
郭晓庆 , 朱任良 , 罗秋兰 . 283例变应性鼻炎患者中医体质与证型相关性研究 [J]. 世界中医药 , 2020 , 15 ( 15 ): 2331 - 2335 .
曾菊蓉 , 王武军 , 谢晓红 , 等 . 针刺配合穴位贴敷及药物治疗过敏性鼻炎的疗效观察 [J]. 上海针灸杂志 , 2020 , 39 ( 7 ): 893 - 898 .
余阳 , 陈星宇 , 罗月红 , 等 . 基于数据挖掘探究针灸治疗过敏性鼻炎的用穴规律 [J]. 世界中医药 , 2021 , 16 ( 12 ): 1839 - 1842,1848 .
巩政 , 闫占峰 , 刘巧平 , 等 . 鼻内针刺对变应性鼻炎兔神经源性炎性反应的影响 [J]. 针刺研究 , 2021 , 46 ( 2 ): 111 - 116,122 .
巩政 , 闫占峰 , 刘巧平 , 等 . 鼻内针刺治疗持续性中重度变应性鼻炎的临床研究 [J]. 中国中西医结合杂志 , 2020 , 40 ( 12 ): 1458 - 1463 .
曹春梅 , 庞维荣 , 白舒霞 , 等 . 辛夷苍耳加减方对老年变应性鼻炎伴发哮喘患者EOS、IgE及炎症因子的影响 [J]. 中国中医基础医学杂志 , 2021 , 27 ( 1 ): 92 - 95 .
樊华 , 覃泰杰 , 叶林松 , 等 . 接受免疫治疗的变应性鼻炎儿童患者外周血中IL-25、IL-33的表达和EOS计数及意义 [J]. 临床耳鼻咽喉头颈外科杂志 , 2018 , 32 ( 6 ): 443 - 446 .
蔡一宁 , 吴紫陆 , 王俊杰 , 等 . 鼻康复调控IL-35/STAT3抑制嗜酸性粒细胞活化及免疫功能抗变应性鼻炎作用机制 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 9 ): 110 - 116 .
0
浏览量
31
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621